Targeting of cancer neoantigens with donor-derived T cell receptor repertoiresErlend Strønen, Ton N. Schumacher, Mireille Toebes et al.|Science|2016Cited by 448
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trialsAlain Amstutz, Matthias Briel, Lori E. Dodd et al.|The Lancet Respiratory Medicine|2023Cited by 124
Robust spike-specific CD4+ and CD8+ T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort studyLorenzo Federico, Ludvig A. Munthe, Tor Henrik Anderson Tvedt et al.|Frontiers in Immunology|2023Cited by 8
People who use drugs show no increase in pre-existing T-cell cross-reactivity toward SARS-CoV-2 but develop a normal polyfunctional T-cell response after standard mRNA vaccinationMurat Gainullin, Ludvig A. Munthe, Lorenzo Federico et al.|Frontiers in Immunology|2024Cited by 0